Expectations had been high that the therapy, sigvotatug vedotin, could replace docetaxel, a widely used chemotherapy.
In this week's edition of "Adam's Biotech Scorecard," Adam also weighs in on Abivax as it tries again to squelch cancer-risk fears about its therapy.
AI will be necessary for the next major pancreatic cancer advances — but not for reasons you might expect.
Treating cancer patients is difficult. But it also brings special moments of joy and connection, an oncologist writes.
Play: What's the word? Test your knowledge with today's mini crossword
